Crescent Biopharma, Inc. SEC filings CBIO

Crescent Biopharma, Inc. has 676 filings in SEC EDGAR's recent list, going back to Jul 10, 2003. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 30, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.

Crescent Biopharma, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 15, 2026 Oct 15, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
8-K Current report
Other events
Jul 15, 2026 Jul 14, 2026
8-K Current report
Results of operations
Jul 14, 2026 Jul 14, 2026
8-K Current report
Shareholder vote results
Jun 3, 2026 Jun 2, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Dec 4, 2025 Dec 2, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Results of operations, Officer or director change
Jul 31, 2025 Jul 29, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Results of operations, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Jun 18, 2025 Jun 13, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure, Other events
Jun 6, 2025 Jun 5, 2025
8-K Current report
Other events
May 30, 2025 May 30, 2025
8-K Current report
Material agreement
Apr 29, 2025 Apr 28, 2025
8-K Current report
Agreement ended, Officer or director change
Feb 25, 2025 Feb 19, 2025
8-K Current report
Material agreement
Feb 14, 2025 Feb 14, 2025
8-K Current report
Officer or director change
Jan 31, 2025 Jan 29, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Listing notice
Dec 26, 2024 Dec 19, 2024
8-K Current report
Regulation FD disclosure
Nov 7, 2024 Nov 7, 2024
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure, Other events
Oct 29, 2024 Oct 28, 2024
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Jul 30, 2024 Jul 24, 2024
8-K Current report
Listing notice
Jun 26, 2024 Jun 21, 2024
8-K Current report
Officer or director change
Jun 13, 2024 Jun 10, 2024
8-K Current report
Regulation FD disclosure
Jun 4, 2024 Jun 4, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2024 May 6, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 2, 2024 May 1, 2024
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
8-K Current report
Regulation FD disclosure
Mar 1, 2024 Mar 1, 2024
8-K Current report
Material agreement
Jan 2, 2024 Jan 2, 2024
8-K Current report
Results of operations
Nov 3, 2023 Nov 3, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Shareholder vote results
May 22, 2023 May 19, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
8-K Current report
Material agreement
Apr 21, 2023 Apr 19, 2023
8-K Current report
Results of operations
Mar 29, 2023 Mar 29, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
8-K Current report
Regulation FD disclosure
Mar 2, 2023 Mar 2, 2023
8-K Current report
Officer or director change
Feb 21, 2023 Feb 21, 2023
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Regulation FD disclosure
Oct 4, 2022 Oct 4, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Listing notice
Jun 3, 2022 May 31, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 20, 2022 May 18, 2022
8-K Current report
Results of operations
Apr 28, 2022 Apr 28, 2022
8-K Current report
Results of operations
Mar 3, 2022 Mar 3, 2022
8-K Current report
Officer or director change, Other events
Jan 27, 2022 Jan 21, 2022
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
Aug 5, 2021 Jul 30, 2021
8-K Current report
Shareholder vote results
May 20, 2021 May 18, 2021
8-K Current report
Results of operations
May 3, 2021 May 3, 2021
8-K Current report
Results of operations
Mar 2, 2021 Mar 2, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 23, 2021 Feb 19, 2021
8-K Current report
Results of operations
Nov 6, 2020 Nov 6, 2020
8-K Current report
Material agreement
Oct 7, 2020 Oct 7, 2020
8-K Current report
Results of operations
Jul 31, 2020 Jul 31, 2020
8-K Current report
Shareholder vote results
May 26, 2020 May 22, 2020
8-K Current report
Results of operations
May 1, 2020 May 1, 2020
8-K Current report
Results of operations, Other events
Feb 28, 2020 Feb 28, 2020
8-K Current report
Agreement ended
Feb 10, 2020 Feb 5, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Jan 7, 2020 Jan 2, 2020
8-K Current report
Regulation FD disclosure
Nov 21, 2019 Nov 21, 2019
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
8-K Current report
Other events
Aug 5, 2019 Aug 2, 2019
8-K Current report
Results of operations
Aug 1, 2019 Aug 1, 2019
8-K Current report
Shareholder vote results
May 17, 2019 May 17, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
8-K Current report
Results of operations
Mar 6, 2019 Mar 6, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 5, 2019 Mar 1, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 28, 2018 Nov 27, 2018
8-K Current report
Results of operations
Nov 2, 2018 Nov 2, 2018
8-K Current report
Results of operations
Aug 9, 2018 Aug 9, 2018
8-K Current report
Regulation FD disclosure
Jul 25, 2018 Jul 23, 2018
8-K Current report
Shareholder vote results
May 21, 2018 May 18, 2018
8-K Current report
Results of operations
May 3, 2018 May 3, 2018
8-K Current report
Material agreement, Other events
Mar 21, 2018 Mar 20, 2018
8-K Current report
Results of operations
Mar 6, 2018 Mar 6, 2018
8-K Current report
Results of operations
Nov 8, 2017 Nov 8, 2017
8-K Current report
Material agreement
Sep 28, 2017 Sep 28, 2017
8-K Current report
Results of operations
Aug 3, 2017 Aug 3, 2017
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 12, 2017 Jun 9, 2017
8-K Current report
Material agreement, Shareholder vote results, Other events
May 25, 2017 May 24, 2017
8-K Current report
Agreement ended
May 24, 2017 May 23, 2017
8-K Current report
Results of operations
May 8, 2017 May 8, 2017
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 13, 2017 Mar 9, 2017
8-K Current report
Results of operations
Mar 1, 2017 Mar 1, 2017
8-K Current report
Results of operations
Nov 4, 2016 Nov 4, 2016
8-K Current report
Officer or director change
Sep 23, 2016 Sep 20, 2016
8-K Current report
Results of operations
Aug 4, 2016 Aug 4, 2016
8-K Current report
Material agreement, Other events
Jun 17, 2016 Jun 16, 2016
8-K Current report
Regulation FD disclosure
Jun 10, 2016 Jun 10, 2016
8-K Current report
Other events
Jun 2, 2016 Jun 2, 2016
8-K Current report
Shareholder vote results
May 18, 2016 May 17, 2016
8-K Current report
Results of operations
May 4, 2016 May 4, 2016
8-K Current report
Material agreement
Mar 29, 2016 Mar 24, 2016
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 21, 2016 Mar 21, 2016
8-K Current report
Material agreement
Mar 1, 2016 Mar 1, 2016
8-K Current report
Results of operations
Feb 29, 2016 Feb 29, 2016
8-K Current report
Results of operations
Nov 12, 2015 Nov 12, 2015
8-K Current report
Results of operations
Aug 6, 2015 Aug 6, 2015
8-K Current report
Shareholder vote results
Jul 20, 2015 Jul 15, 2015
8-K Current report
Results of operations
May 5, 2015 May 5, 2015
8-K Current report
Regulation FD disclosure
Apr 7, 2015 Apr 7, 2015
8-K Current report
Results of operations
Mar 16, 2015 Mar 16, 2015
8-K Current report
Results of operations
Oct 31, 2014 Oct 31, 2014
8-K Current report
Regulation FD disclosure
Sep 26, 2014 Sep 26, 2014
8-K Current report
Results of operations
Jul 31, 2014 Jul 31, 2014
8-K Current report
Material agreement
Jul 28, 2014 Jul 23, 2014
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 10, 2014 Jul 8, 2014
8-K Current report
Results of operations
May 8, 2014 May 8, 2014
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Apr 4, 2014 Mar 31, 2014
8-K Current report
Listing notice
Mar 14, 2014 Mar 10, 2014
8-K Current report
Bylaw or fiscal year change
Jan 15, 2014 Jan 15, 2014

Showing 113 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Waltham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1253689
Former names
GLYCOMIMETICS INC (until Jun 23, 2025)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.